Afinitor (everolimus) 10 mg film-coated tablets, 30 tablets — original (Novartis, Switzerland) Targeted cancer therapy. Delivery of medications from Europe and beyond within 4-5 days, storage conditions observed, payment upon receipt. Order by calling +380996042415, Viber, WhatsApp.

Interchangeable drugs with the same active substance:

• Afinitor
• Evertor
• Evertor

Indications

• Treatment in combination with exemestane of advanced hormone-receptor-positive, HER2-negative breast cancer in postmenopausal women who do not have rapidly progressive internal organ disease, if previous therapy with non-steroidal aromatase inhibitors resulted in recurrence or progression.
• Treatment of patients with renal cell carcinoma Advanced-stage pancreatic carcinoma whose disease progresses with or after VEGF (vascular endothelial growth factor) therapy.
• Treatment of unresectable or metastatic, well- or moderately differentiated neuroendocrine tumors of the pancreas in adult patients with progressive disease.
• Treatment of patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC) requiring therapeutic intervention other than surgery.
• Changes in SEGA volume are evidence of treatment efficacy. No further clinical benefit, such as improvement in disease-related symptoms, was observed.
• Treatment of adult patients with renal angiomyolipoma associated with tuberous sclerosis complex (TSC) who are at risk for complications (e.g., tumor size, presence of aneurysm, presence of multiple tumors, or bilateral tumors) that do not require surgical intervention.
• Evidence of treatment efficacy is provided by analysis of changes in the total angiomyolipoma volume.